Nifedipine Tablet, Extended Release
Product Images NDC 71610-841

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 71610-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0841 60)

Nifedipine ER, USP 30 mg extended-release tablets label showing a 90-tablet package. The label includes storage instructions, manufacturer information listing Novast Laboratories Ltd. in Nantong, China, and the packager Aphena Pharma Solutions in Cookeville, TN. The NDC number 71610-841-60 is displayed along with batch and expiration placeholders.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Image1 (Image 01)

Chemical structure of nifedipine, showing a dihydropyridine ring with methyl, methoxycarbonyl, acetyl, nitro, and phenyl substituents.*

FDA Label Image

Image2 (Image 02)

A data table displaying mean reductions in trough supine blood pressure (systolic/diastolic in mmHg) for nifedipine extended-release tablets across different doses (30 mg, 60 mg, 90 mg) in two separate studies. The table includes sample sizes (N) and notes that placebo response is subtracted.*

FDA Label Image

Image3 (Image 03)

A data table comparing the percentage incidence of adverse effects in patients taking Nifedipine extended-release tablets (30 mg, n=370) versus placebo (n=126). Adverse effects include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation, with higher reported percentages for headache and flushing in the Nifedipine group compared to placebo.*

FDA Label Image

Image4 (Image 04)

Text panel listing nifedipine tablet strengths (30 mg, 60 mg, 90 mg) with corresponding colors (yellow, pink, brown) and marking details, including 'Novast' on one side and numeric codes on the other side of each tablet.*

FDA Label Image

Image5 (Image 05)

This table lists bottle sizes, strengths, and corresponding NDC codes for nifedipine extended-release tablets. It includes bottles of 100 tablets with strengths of 30 mg, 60 mg, and 90 mg. Each strength is associated with a unique NDC code.*

FDA Label Image

Image6 (Image 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.